Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Johncan International appears to be the trade name used by Hangzhou Johncan Mushroom Bio-Technology, a China-based manufacturer and exporter of edible and medicinal mushroom ingredients, extracts, and related nutraceutical products. The company focuses on the research, development, production, and sale of mushroom-derived powders, extracts, polysaccharides, beta glucans, and supplement formulations rather than prescription drug development. Its product portfolio includes reishi, cordyceps, lion's mane, shiitake, maitake, chaga, oyster mushroom, and oat or yeast beta glucan ingredients sold into supplement, functional food, cosmetics, beverage, and broader health-product markets. Johncan states that it operates GMP-compliant fermentation and extraction workshops and has supplied customers in Japan, the United States, and Europe. Based on the available evidence, it is best characterized as a commercial nutraceutical and botanical ingredient company with healthcare adjacency, not a clinical-stage biopharma developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Johncan International.